2025-10-24 - Analysis Report
Okay, here's an analysis of Albemarle Corp (ALB) based on the data provided.

**Report on Albemarle Corp (ALB)**

Albemarle Corp (ALB) is a specialty chemicals company, known for lithium, bromine specialties, and catalysts.

**1. Performance vs. S&P 500 (VOO)**

*   **Cumulative Return:**
    *   ALB: -12.48%
    *   VOO: 99.09%
*   **Disparity:**
    *   Current Disparity: -107.5
    *   Relative Disparity: 4.2 (Indicates ALB is near the lower end of its historical performance range relative to VOO)

**Analysis of Alpha/Beta & Performance Metrics:**

Here's a table summarizing the Alpha/Beta and performance metrics provided:

| Year       | CAGR     | MDD      | Alpha    | Beta   | Cap(B) |
|------------|----------|----------|----------|--------|--------|
| 2015-2017  | 77.0%    | 74.3%    | 49.0%    | 0.0    | 16.0   |
| 2016-2018  | 12.0%    | 67.8%    | -4.0%    | 0.0    | 9.7    |
| 2017-2019  | -41.0%   | 73.9%    | -63.0%   | 0.3    | 9.2    |
| 2018-2020  | 45.0%    | 79.3%    | 21.0%    | 0.3    | 18.5   |
| 2019-2021  | 148.0%   | 79.3%    | 102.0%   | 0.4    | 29.3   |
| 2020-2022  | 147.0%   | 80.0%    | 148.0%   | 0.5    | 27.2   |
| 2021-2023  | -25.0%   | 81.9%    | -26.0%   | 0.5    | 18.1   |
| 2022-2024  | -150.0%  | 81.9%    | -171.0%  | 0.7    | 10.8   |
| 2023-2025  | -231.0%  | 81.9%    | -294.0%  | 0.5    | 11.5   |

*   **Key Observations:**
    *   **Recent Underperformance:**  The CAGR (Compound Annual Growth Rate) has been significantly negative in the most recent periods (2021-2025).
    *   **High Volatility:**  MDD (Maximum Drawdown) is consistently high, indicating significant price volatility.
    *   **Negative Alpha:** The alpha is strongly negative in the recent periods, suggesting that the stock has underperformed its benchmark (S&P 500) after adjusting for risk (beta).
    *   **Increasing Beta:** Beta has generally increased over time, implying that the stock's price movements have become more correlated with the overall market.

**2. Recent Price Action**

*   **Current Price:** $91.34
*   **Last Market Activity:** Price: $97.36, Previous Close: $91.27, Change: $6.67 (Significant upward movement)
*   **Moving Averages:**
    *   5-day MA: $94.73
    *   20-day MA: $89.83
    *   60-day MA: $81.90

**Analysis:** The recent price surge is evident, with the current price above all three moving averages.  The strong positive change in the last market activity suggests a potential short-term bullish trend, although further confirmation is needed.

**3. Technical Indicators**

*   **Market Risk Indicator (MRI):** 0.9 (High Investment Recommended)
*   **RSI:** 60.03 (Approaching overbought territory)
*   **PPO:** -0.07 (Slightly negative, indicating potential short-term weakness before the recent jump)
*   **Hybrid Signal:** cash_0%_Buy 100% of cash (12 shares - Very Safe - MRI:0.90) Monthly invest 0.8% of total investment ($1,000.00) (Cash Ratio: 0% on 2025-10-01)
*   **Recent (20-day) Relative Disparity Change:** -0.1 (Short-term decline)
*   **Expected Return:** 699.7% (Long-term, relative to S&P 500)

**Analysis:**
*   The MRI suggests a high level of investment suitability, which seems at odds with the recent performance data.
*   The RSI indicates increasing buying pressure but is not yet at an extremely overbought level.
*   The large positive price change suggests a significant market reaction to some event.
*   The extremely high expected return should be viewed with caution. It represents a long-term projection and may not be reliable, especially given the company's recent performance.

**4. Recent News & Significant Events**

*   **Ketjen, Axens Reach New Eurecat Relationship and Collaboration Agreements:**  Positive news suggesting strategic partnerships.
*   **Analyst Optimism on Lithium Prices Shift the Long-Term Story for Albemarle (ALB)?** Focuses on the potential for lithium price increases to positively impact Albemarle.
*   **How the Story for Albemarle Is Shifting as Analysts Update Forecasts and Valuations:** Indicates a re-evaluation of the company's prospects.
*   **Albemarle Earnings Preview: What to Expect:** Upcoming earnings are a key catalyst.
*   **Albemarle Corporation (ALB) is Attracting Investor Attention: Here is What You Should Know:**  Suggests increased interest in the stock.
*   **Rare Earth Boom: Defense Heavyweight Joins Critical Mineral Effort:** Could indirectly benefit Albemarle if it plays a role in critical mineral supply chains.

**4-2. Analyst Opinions**

*   **Consensus:** Hold
*   **Mean Recommendation:** 2.72 (Hold)
*   **Target Price:** Average: $93.83, High: $200.00, Low: $58.00

**Analysis:**  The analyst consensus is currently "Hold."  The wide range in target prices reflects significant uncertainty about the company's future performance.

**5. Recent Earnings Analysis**

| 날짜       | EPS    | 매출        |
|------------|--------|-------------|
| 2025-08-04 | -0.16  | 1.33 B$     |
| 2025-04-30 | 0      | 1.08 B$     |
| 2024-11-06 | -9.45  | 1.35 B$     |
| 2024-07-31 | -1.96  | 1.43 B$     |
| 2025-08-04 | -1.96  | 1.43 B$     |

**Analysis:**
*   Recent EPS (Earnings Per Share) figures have been negative, indicating unprofitability.
*   Revenue has fluctuated but generally remained in the $1B-$1.5B range.

**6. Financial Information**

**Revenue and Profitability:**

| Quarter      | Revenue    | Profit Margin |
|--------------|------------|---------------|
| 2025-06-30   | $1.33B     | 14.80%       |
| 2025-03-31   | $1.08B     | 14.51%       |
| 2024-12-31   | $1.23B     | 11.22%       |
| 2024-09-30   | $1.35B     | -7.68%        |
| 2024-06-30   | $1.43B     | -0.74%        |

**Capital and Profitability:**

| Quarter      | Equity     | ROE       |
|--------------|------------|-----------|
| 2025-06-30   | $10.24B    | 0.22%     |
| 2025-03-31   | $10.03B    | 0.41%     |
| 2024-12-31   | $9.96B     | 0.76%     |
| 2024-09-30   | $10.24B    | -10.44%    |
| 2024-06-30   | $11.22B    | -1.68%     |

**Analysis:**

*   Profit margins have been volatile and recently turned positive.
*   ROE (Return on Equity) has been low and negative in some quarters, indicating inefficient use of equity to generate profits.

**7. Overall Summary**

Albemarle (ALB) has significantly underperformed the S&P 500 recently. Its historical performance shows periods of high growth and periods of substantial decline. Recent earnings have been negative, and profitability has been inconsistent.

*   **Positives:**
    *   The MRI suggests investment suitability.
    *   Recent news indicates potential catalysts (lithium prices, strategic partnerships, and renewed analyst interest).
    *   Significant price jump signals potential change in sentiment.

*   **Negatives:**
    *   Recent underperformance relative to the S&P 500.
    *   Negative earnings and volatile profit margins.
    *   High maximum drawdowns indicate significant price risk.
    *   Analyst consensus is a "Hold," reflecting uncertainty.
    *   The extremely high expected return (699.7%) seems unrealistic given the company's recent financial performance and the current market conditions.

**Conclusion:**

ALB presents a mixed picture. The recent positive price movement and analyst attention suggest a potential turnaround. However, investors should be cautious due to the company's recent underperformance, negative earnings, and high volatility. Upcoming earnings will be crucial in determining the stock's future direction. The "Hold" rating from analysts reflects this uncertainty. Further research and careful consideration of risk tolerance are warranted before making any investment decisions.

